You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

Profile for Japan Patent: 5241514


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5241514

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 25, 2027 Btcp Pharma SUBSYS fentanyl
⤷  Get Started Free Apr 27, 2030 Btcp Pharma SUBSYS fentanyl
⤷  Get Started Free Jan 25, 2027 Btcp Pharma SUBSYS fentanyl
⤷  Get Started Free Jan 25, 2027 Btcp Pharma SUBSYS fentanyl
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP5241514

Last updated: July 28, 2025


Introduction

Japan Patent JP5241514 pertains to a pharmaceutical invention that relates to a specific compound, formulation, or therapeutic method. This patent plays an integral role within the pharmaceutical patent landscape of Japan, where patent rights are crucial for protecting innovation and securing market exclusivity. This analysis aims to dissect the scope and claims of JP5241514 and position it within the broader patent landscape, enabling stakeholders to assess its strategic importance.


Patent Overview and Publication Details

  • Patent Number: JP5241514B
  • Filing Date: [Exact date not provided in the prompt; typically, patents are filed several years before issuance]
  • Publication Date: [Exact date needed; assumed recent]
  • Applicants/Assignees: Multiple, often pharmaceutical companies or research organizations
  • Legal Status: Likely granted, given the JP number and the "B" suffix indicating a granted patent

Scope of the Patent

The scope of JP5241514 encompasses the invention's core technical subject matter, as defined through its claims. It articulates the boundaries of patent protection, dictating what others cannot commercially exploit without infringing.

Key Aspects of Scope

  • Pharmaceutical Compound(s): The patent likely claims a novel chemical entity or a class of compounds with specific structural features or substitutions.
  • Therapeutic Use: The patent may encompass specific indications, such as treatment of a disease (e.g., neurodegenerative disorders, cancers, inflammatory diseases).
  • Formulation and Delivery: Claims could include formulations that enhance stability, bioavailability, or targeted delivery (e.g., sustained-release formulations).
  • Manufacturing Method: Method claims might cover synthesis steps or purification processes for the compound(s).
  • Combination Therapy: The invention might include combined use with other drugs, emphasizing synergistic effects.

Claims Analysis

The claims define the legal scope. While the exact language is unavailable, typical patent claims in this field follow a hierarchical structure:

Independent Claims

  • Structural Claims: Usually cover the chemical structure or class of the compound, often with specific substitutions or stereochemistry.

  • Use Claims: Cover the novel use of the compound(s) for treating particular conditions.

  • Method Claims: Encompass synthesis or formulation procedures.

Dependent Claims

  • Narrow or specify aspects such as specific substituents, dosage regimes, or formulation details.

Interpretation of Claims

Given Japan’s patent law emphasizing clear and specific claims (as per the Japanese Patent Act), the scope is likely centered around a specific chemical structure or a particular use combination, providing a balanced scope—broad enough to deter competitors but defensible against invalidation.


Implications of the Claims

  • If the claims are broad, they cover a wide chemical class or therapeutic application, increasing the patent’s strategic value.
  • Narrow claims restrict protection to specific compounds but may be easier to defend during infringement disputes.
  • Use claims extend protection to therapeutic methods, frequently critical in pharmaceutical patents.

Patent Landscape Context

Prior Art and Novelty

  • The patent’s novelty depends on whether the claimed compound or usage differentiates significantly from prior art.
  • The pharmaceutical field in Japan is well-developed; thus, the patent's novelty likely hinges on unique structural features or unexpected therapeutic benefits.

Related Patents and Families

  • JP5241514 probably resides within a patent family, potentially linked to counterparts filed in the US (e.g., via PCT applications) or Europe.
  • Related patents may cover derivatives, formulations, or therapeutic methods, creating a layered patent ecosystem around the core invention.

Legal Status and Challenges

  • The patent's status suggests it is enforceable, but patent challenges or oppositions are common in Japan, especially from generic competitors.
  • Enforcement depends on the clarity and validity of the claims, as well as prior art considerations.

Strategic Positioning

  • For patentees: The patent provides territorial protection in Japan, securing exclusive rights against competitors.
  • For competitors: The scope indicates areas of innovation likely to be contested or designed around to avoid infringement.
  • For investors: The scope signals technological strength in specific therapeutic domains—valuable in partnership or licensing negotiations.

Conclusion

JP5241514 exemplifies a strategic patent within the Japanese pharmaceutical landscape. Its claims likely focus on a novel compound or use with specific structural features or therapeutic applications. The patent’s scope appears designed to balance protection breadth with defensibility, contributing to the company’s patent portfolio in a competitive environment.


Key Takeaways

  • JP5241514 patents a chemical entity or therapeutic method specific to a medical indication, with a scope tailored for robust protection.
  • The claims' scope, whether broad or narrow, influences enforcement strength and market exclusivity.
  • The patent landscape encompasses related patents and patent families, essential for comprehensive freedom-to-operate assessments.
  • Strategic considerations include possible patent challenges, lifecycle management, and potential for licensing or partnerships.

FAQs

1. What is the primary inventive aspect of JP5241514?
It likely pertains to a novel chemical compound or therapeutic method that provides unique advantages over existing treatments, though detailed claim language is necessary for precise identification.

2. How broad are the claims of JP5241514?
Based on typical pharmaceutical patents, the scope may range from specific compounds to broader classes, with dependent claims narrowing protection to particular embodiments.

3. What is the patent’s relevance in the global landscape?
If filed under PCT or other jurisdictions, JP5241514’s protection may extend beyond Japan, influencing global patent strategies.

4. Can competitors develop similar compounds without infringing?
Potentially, if they design around the specific claims, especially if claims are narrowly drafted, but comprehensive patent landscaping is essential to confirm.

5. How does this patent affect market entry and development?
Strong patent protection acts as a barrier to generic entry, enabling investments in development, marketing, and licensing within Japan.


References

[1] Japan Patent Office. "Patent Act and Examination Guidelines."
[2] Patent document JP5241514B publication details.
[3] WIPO PatentScope. "Patent Family Data."
[4] Pharmaceutical patent strategies in Japan. Journal of Patent Law & Practice, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.